| Pharmaceutical active ingredients: |
| Ondansetron |
| Available forms, composition and doses of Zofran Melt: |
| Powder for Solution; Oral; Ondansetron 4 mgPowder for Solution; Oral; Ondansetron 8 mg |
| Zofran Melt medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Zofran Melt: |
| Zofran injection prescribing information (PDF)Zofran tablets prescribing information (PDF) |